NX-1207

· Nymox Corporation

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for NX-1207, covering 2012-06-14 to 2022-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH [Phase 3]

See pricing